Effect of salbutamol on smoking related cough

Pulmonary Pharmacology and Therapeutics

Volumn 17, Issue 3, 2004, Pages 127-131

  Mulrennan, Siobhan ^a   Wright, Caroline ^a   Thompson, Rachel ^a   Goustas, Peter ^b   Morice, Alyn ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Agonists; Anti tussives; Cough; Smoking

Indexed keywords

ANTITUSSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CITRIC ACID; PLACEBO; SALBUTAMOL;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DATA ANALYSIS; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TREATMENT OUTCOME;

ADULT; ALBUTEROL; ANTITUSSIVE AGENTS; COUGH; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METERED DOSE INHALERS; MIDDLE AGED; SMOKING;

EID: 1942422131     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pupt.2004.01.002     Document Type: Article

References (17)

1. Janson C., Chinn S., Jarvis D., et al. Determinants of cough in young adults participating in the European Community Respiratory Health Survey. Eur Respir J. 18:1991;647-654.
2. Gerrard J.W., Cockcroft D.W., Mink J.T., et al. Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis. 122:1980;577-581.
3. Cullinan P. Persistent cough and sputum: prevalence and clinical characteristics in south east England. Resp Med. 86:1992;143-149.
4. Pounsford J.C., Birch M.J., Saunders K.B. Effect of bronchodilators on the cough response to inhaled citric acid in normal and asthmatic subjects. Thorax. 40:1985;662-667.
5. Crapo R.O., Casaburi R., Coates A.L., et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 161:2000;309-329.
6. Middleton E.T., Morice A.H. Breath carbon monoxide as an indication of smoking habit. Chest. 117:2000;758-763.
7. Morice A.H., Kastelik J.A., Thompson R. Cough challenge in the assessment of cough reflex. Br J Clin Pharmacol. 52:2001;365-375.
8. Wong C.H., Morice A.H. Cough threshold in patients with chronic obstructive pulmonary disease. Thorax. 54:1999;62-64.
9. Turato G., Di Stefano A., Maestrelli P., et al. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med. 152:1995;1262-1267.
10. Wright J.L., Hobson J.E., Wiggs B., et al. Airway inflammation and peribronchiolar attachments in the lungs of nonsmokers, current and ex-smokers. Lung. 166:1988;277-286.
11. O'Connell F., Thomas V.E., Pride N.B., et al. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med. 150:1994;374-380.
12. Hunter C.J., Brightling C.E., Woltmann G., et al. A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 121:2002;1051-1057.
13. Rokach J., Khanapure S.P., Hwang S.W., et al. Nomenclature of isoprostanes: a proposal. Prostaglandins. 54:1997;853-873.
14. Pratico D., Basili S., Vieri M., et al. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med. 158:1998;1709-1714.
15. Morrow J.D., Frei B., Longmire A.W., et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 332:1995;1198-1203.
16. Nichol G., Nix A., Barnes P.J., et al. Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. Thorax. 45:1990;694-698.
17. Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature. 421:2003;384-388.